

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.58026504 |
| 2 | negative T cell selection (GO:0043383) | 6.28980025 |
| 3 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.14265050 |
| 4 | negative thymic T cell selection (GO:0045060) | 5.87519820 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.78361916 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.78361916 |
| 7 | cellular response to interleukin-15 (GO:0071350) | 5.71867937 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.67904350 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.67859260 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.67859260 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.66357395 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 5.54129631 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.54129631 |
| 14 | response to interleukin-15 (GO:0070672) | 5.51245810 |
| 15 | cytidine metabolic process (GO:0046087) | 5.38437992 |
| 16 | cytidine catabolic process (GO:0006216) | 5.38437992 |
| 17 | cytidine deamination (GO:0009972) | 5.38437992 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 5.30445018 |
| 19 | positive T cell selection (GO:0043368) | 5.19888350 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.10463253 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.03133069 |
| 22 | positive thymic T cell selection (GO:0045059) | 4.99250743 |
| 23 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.99050922 |
| 24 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.95699813 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 4.93875642 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 4.93875642 |
| 27 | tryptophan catabolic process (GO:0006569) | 4.93875642 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 4.89313654 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 4.88686780 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.85971654 |
| 31 | urea metabolic process (GO:0019627) | 4.82671560 |
| 32 | urea cycle (GO:0000050) | 4.82671560 |
| 33 | kynurenine metabolic process (GO:0070189) | 4.82184582 |
| 34 | T cell migration (GO:0072678) | 4.78166636 |
| 35 | bile acid biosynthetic process (GO:0006699) | 4.73045258 |
| 36 | thymic T cell selection (GO:0045061) | 4.72887341 |
| 37 | activated T cell proliferation (GO:0050798) | 4.71343928 |
| 38 | DNA deamination (GO:0045006) | 4.68694183 |
| 39 | tryptophan metabolic process (GO:0006568) | 4.66499443 |
| 40 | regulation of regulatory T cell differentiation (GO:0045589) | 4.65243379 |
| 41 | regulation of protein activation cascade (GO:2000257) | 4.58752372 |
| 42 | T cell selection (GO:0045058) | 4.56593371 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.55003627 |
| 44 | negative regulation of fibrinolysis (GO:0051918) | 4.50026664 |
| 45 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.46857511 |
| 46 | protein carboxylation (GO:0018214) | 4.46790999 |
| 47 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.46790999 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 4.46735840 |
| 49 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.45825718 |
| 50 | nitrogen cycle metabolic process (GO:0071941) | 4.39811836 |
| 51 | regulation of complement activation (GO:0030449) | 4.36019421 |
| 52 | cysteine metabolic process (GO:0006534) | 4.32955536 |
| 53 | glyoxylate metabolic process (GO:0046487) | 4.31390368 |
| 54 | high-density lipoprotein particle remodeling (GO:0034375) | 4.30814918 |
| 55 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.29930138 |
| 56 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.29930138 |
| 57 | regulation of triglyceride catabolic process (GO:0010896) | 4.28017739 |
| 58 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.26250064 |
| 59 | regulation of fibrinolysis (GO:0051917) | 4.26082874 |
| 60 | regulation of B cell differentiation (GO:0045577) | 4.24014324 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 4.22459295 |
| 62 | homocysteine metabolic process (GO:0050667) | 4.22166121 |
| 63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.21027538 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 4.17867998 |
| 65 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.14563173 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 4.13534640 |
| 67 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.10279531 |
| 68 | interferon-gamma production (GO:0032609) | 4.08688436 |
| 69 | bile acid metabolic process (GO:0008206) | 4.06551650 |
| 70 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.05865344 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 4.04408878 |
| 72 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.03562051 |
| 73 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.98197538 |
| 74 | phospholipid efflux (GO:0033700) | 3.98145535 |
| 75 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.92090792 |
| 76 | B cell receptor signaling pathway (GO:0050853) | 3.91013663 |
| 77 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.90177916 |
| 78 | serine family amino acid catabolic process (GO:0009071) | 3.88982632 |
| 79 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.88569483 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.87683233 |
| 81 | negative regulation of sterol transport (GO:0032372) | 3.85423530 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 3.85423530 |
| 83 | positive regulation of defense response to virus by host (GO:0002230) | 3.84924909 |
| 84 | reverse cholesterol transport (GO:0043691) | 3.83324012 |
| 85 | type I interferon signaling pathway (GO:0060337) | 3.82226131 |
| 86 | cellular response to type I interferon (GO:0071357) | 3.82226131 |
| 87 | lysine catabolic process (GO:0006554) | 3.82035952 |
| 88 | lysine metabolic process (GO:0006553) | 3.82035952 |
| 89 | phospholipid homeostasis (GO:0055091) | 3.80961890 |
| 90 | response to type I interferon (GO:0034340) | 3.79818002 |
| 91 | positive regulation of cell killing (GO:0031343) | 3.78892527 |
| 92 | positive regulation of granulocyte differentiation (GO:0030854) | 3.78470912 |
| 93 | valine metabolic process (GO:0006573) | 3.78208130 |
| 94 | aromatic amino acid family metabolic process (GO:0009072) | 3.76798809 |
| 95 | positive regulation of tolerance induction (GO:0002645) | 3.76763064 |
| 96 | protein-lipid complex remodeling (GO:0034368) | 3.76237223 |
| 97 | macromolecular complex remodeling (GO:0034367) | 3.76237223 |
| 98 | plasma lipoprotein particle remodeling (GO:0034369) | 3.76237223 |
| 99 | acylglycerol homeostasis (GO:0055090) | 3.74532050 |
| 100 | triglyceride homeostasis (GO:0070328) | 3.74532050 |
| 101 | positive regulation of humoral immune response (GO:0002922) | 3.72047066 |
| 102 | ethanol oxidation (GO:0006069) | 3.67675232 |
| 103 | regulation of cholesterol esterification (GO:0010872) | 3.66471354 |
| 104 | regulation of cell killing (GO:0031341) | 3.66070118 |
| 105 | amino-acid betaine metabolic process (GO:0006577) | 3.65699526 |
| 106 | tyrosine metabolic process (GO:0006570) | 3.64830119 |
| 107 | T cell receptor signaling pathway (GO:0050852) | 3.63832802 |
| 108 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.63385043 |
| 109 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.61686074 |
| 110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.61686074 |
| 111 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.61411096 |
| 112 | regulation of tolerance induction (GO:0002643) | 3.60821468 |
| 113 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.58282713 |
| 114 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.55293302 |
| 115 | alpha-amino acid catabolic process (GO:1901606) | 3.55067255 |
| 116 | positive regulation of lipid catabolic process (GO:0050996) | 3.55047028 |
| 117 | bile acid and bile salt transport (GO:0015721) | 3.51653961 |
| 118 | tolerance induction (GO:0002507) | 3.51415770 |
| 119 | cholesterol efflux (GO:0033344) | 3.49973828 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 3.49298037 |
| 121 | complement activation, classical pathway (GO:0006958) | 3.49150517 |
| 122 | negative regulation of viral genome replication (GO:0045071) | 3.48880072 |
| 123 | complement activation (GO:0006956) | 3.46917381 |
| 124 | indolalkylamine metabolic process (GO:0006586) | 3.43707986 |
| 125 | T cell costimulation (GO:0031295) | 3.39991541 |
| 126 | acetyl-CoA metabolic process (GO:0006084) | 3.39434181 |
| 127 | regulation of cholesterol homeostasis (GO:2000188) | 3.38948826 |
| 128 | lymphocyte costimulation (GO:0031294) | 3.38600045 |
| 129 | coenzyme catabolic process (GO:0009109) | 3.35258246 |
| 130 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.34988494 |
| 131 | cellular response to interferon-beta (GO:0035458) | 3.33758042 |
| 132 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.32003957 |
| 133 | NIK/NF-kappaB signaling (GO:0038061) | 3.31840188 |
| 134 | positive regulation of isotype switching (GO:0045830) | 3.31524496 |
| 135 | regulation of chronic inflammatory response (GO:0002676) | 3.30586728 |
| 136 | cellular glucuronidation (GO:0052695) | 3.29676074 |
| 137 | 2-oxoglutarate metabolic process (GO:0006103) | 3.29572521 |
| 138 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.29560505 |
| 139 | leukocyte aggregation (GO:0070486) | 3.29159935 |
| 140 | fibrinolysis (GO:0042730) | 3.28902909 |
| 141 | low-density lipoprotein particle clearance (GO:0034383) | 3.28500428 |
| 142 | benzene-containing compound metabolic process (GO:0042537) | 3.28477360 |
| 143 | protein-lipid complex assembly (GO:0065005) | 3.28368039 |
| 144 | protein activation cascade (GO:0072376) | 3.28259861 |
| 145 | epoxygenase P450 pathway (GO:0019373) | 3.27960690 |
| 146 | drug catabolic process (GO:0042737) | 3.27588756 |
| 147 | response to interferon-beta (GO:0035456) | 3.26919751 |
| 148 | cellular amino acid catabolic process (GO:0009063) | 3.26842667 |
| 149 | cellular modified amino acid catabolic process (GO:0042219) | 3.24272964 |
| 150 | amine catabolic process (GO:0009310) | 3.22973529 |
| 151 | cellular biogenic amine catabolic process (GO:0042402) | 3.22973529 |
| 152 | negative regulation of interleukin-12 production (GO:0032695) | 3.22919614 |
| 153 | imidazole-containing compound metabolic process (GO:0052803) | 3.21865077 |
| 154 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.20704499 |
| 155 | cholesterol homeostasis (GO:0042632) | 3.19697989 |
| 156 | positive regulation of interleukin-2 production (GO:0032743) | 3.19112930 |
| 157 | positive regulation of B cell mediated immunity (GO:0002714) | 3.18065630 |
| 158 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.18065630 |
| 159 | positive regulation of DNA recombination (GO:0045911) | 3.16327289 |
| 160 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.15235923 |
| 161 | sterol homeostasis (GO:0055092) | 3.15169574 |
| 162 | mast cell activation (GO:0045576) | 3.14976889 |
| 163 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14715876 |
| 164 | glutamate metabolic process (GO:0006536) | 3.13994097 |
| 165 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.13858434 |
| 166 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.13858434 |
| 167 | cytolysis (GO:0019835) | 3.13564177 |
| 168 | negative regulation of lipase activity (GO:0060192) | 3.13034985 |
| 169 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.12983998 |
| 170 | glycine metabolic process (GO:0006544) | 3.12284415 |
| 171 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11911114 |
| 172 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11882393 |
| 173 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.11459904 |
| 174 | regulation of alpha-beta T cell activation (GO:0046634) | 3.11383237 |
| 175 | fatty acid oxidation (GO:0019395) | 3.10539129 |
| 176 | defense response to protozoan (GO:0042832) | 3.10353278 |
| 177 | negative regulation of B cell proliferation (GO:0030889) | 3.09963563 |
| 178 | fatty acid beta-oxidation (GO:0006635) | 3.09586020 |
| 179 | regulation of bile acid biosynthetic process (GO:0070857) | 3.08826966 |
| 180 | negative regulation of adaptive immune response (GO:0002820) | 3.08696459 |
| 181 | acute-phase response (GO:0006953) | 3.08198746 |
| 182 | lipoprotein metabolic process (GO:0042157) | 3.05528636 |
| 183 | fatty acid transmembrane transport (GO:1902001) | 3.04946535 |
| 184 | plasma lipoprotein particle organization (GO:0071827) | 3.03964698 |
| 185 | regulation of humoral immune response (GO:0002920) | 3.03960112 |
| 186 | lipid oxidation (GO:0034440) | 3.03950989 |
| 187 | T cell homeostasis (GO:0043029) | 3.02781996 |
| 188 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.02578916 |
| 189 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.00685243 |
| 190 | cellular defense response (GO:0006968) | 3.00544195 |
| 191 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.99373159 |
| 192 | lymphocyte migration (GO:0072676) | 2.99185245 |
| 193 | positive regulation of T cell mediated immunity (GO:0002711) | 2.99137405 |
| 194 | negative regulation of T cell apoptotic process (GO:0070233) | 2.98552121 |
| 195 | immunoglobulin mediated immune response (GO:0016064) | 2.96764222 |
| 196 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94192843 |
| 197 | regulation of T cell mediated immunity (GO:0002709) | 2.90843858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.52548860 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.17318667 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.47506828 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.12697913 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.02449576 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.75192416 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.84451883 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79526412 |
| 9 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.45819232 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.12729035 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.75391341 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.70959086 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.61864048 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46261110 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.39939280 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.34974142 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.20830305 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20705124 |
| 19 | GATA3_26560356_Chip-Seq_TH2_Human | 2.19693794 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.19655046 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.12706148 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.04497831 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.01302491 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00113522 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.95524533 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.95176435 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.92154246 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84497033 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81270236 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77650537 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76500733 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76077407 |
| 33 | * MAF_26560356_Chip-Seq_TH2_Human | 1.75653770 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72950316 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71041109 |
| 36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.65722141 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64590710 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.63601177 |
| 39 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.61884868 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55582301 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51938373 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.49813041 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49629537 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49256364 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.47914432 |
| 46 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46696173 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42011542 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39089676 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38878291 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33909196 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31021241 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30612235 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30344838 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28015111 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26117762 |
| 56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.25375372 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24876458 |
| 58 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23687061 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20165296 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19598504 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15709779 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14935110 |
| 63 | * MAF_26560356_Chip-Seq_TH1_Human | 1.14008213 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13705498 |
| 65 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13677602 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12087630 |
| 67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11655976 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10028347 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08754573 |
| 70 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.07083332 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06319218 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06043377 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05592216 |
| 74 | * GATA3_26560356_Chip-Seq_TH1_Human | 1.03822002 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02824846 |
| 76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02256036 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01442980 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01262813 |
| 79 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00829730 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99583877 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99196312 |
| 82 | * MYB_26560356_Chip-Seq_TH1_Human | 0.99029220 |
| 83 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98778824 |
| 84 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.98348797 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95620048 |
| 86 | MYB_26560356_Chip-Seq_TH2_Human | 0.94578904 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94351257 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92617517 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91870104 |
| 90 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91259354 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90998154 |
| 92 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90604179 |
| 93 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89424264 |
| 94 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.89307373 |
| 95 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89131457 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89047321 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88050613 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87523707 |
| 99 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87394986 |
| 100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85243155 |
| 101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85242317 |
| 102 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.85132968 |
| 103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85029329 |
| 104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84296195 |
| 105 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84199733 |
| 106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.84126085 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83446782 |
| 108 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83245247 |
| 109 | UTX_26944678_Chip-Seq_JUKART_Human | 0.83150762 |
| 110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82716051 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81903584 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81713243 |
| 113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81030676 |
| 114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80972398 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80378430 |
| 116 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.80149299 |
| 117 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79954584 |
| 118 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.79764852 |
| 119 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79553967 |
| 120 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79394972 |
| 121 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78251370 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78215060 |
| 123 | MYC_22102868_ChIP-Seq_BL_Human | 0.77927898 |
| 124 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77702682 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.77295586 |
| 126 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.77084895 |
| 127 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75582697 |
| 128 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.75565468 |
| 129 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.75295654 |
| 130 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74365715 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73835180 |
| 132 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.73387621 |
| 133 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.73281242 |
| 134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.73044042 |
| 135 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.73018145 |
| 136 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.70442900 |
| 137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.69593356 |
| 138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69500988 |
| 139 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69201052 |
| 140 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.69072264 |
| 141 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.69072264 |
| 142 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.68129260 |
| 143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.68108838 |
| 144 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67972186 |
| 145 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.67863540 |
| 146 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.67497875 |
| 147 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.67454573 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67214341 |
| 149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66054954 |
| 150 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66054954 |
| 151 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65710980 |
| 152 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.65414722 |
| 153 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.64721204 |
| 154 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.64258477 |
| 155 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.63339647 |
| 156 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63148793 |
| 157 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.63015025 |
| 158 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.61778379 |
| 159 | P300_27268052_Chip-Seq_Bcells_Human | 0.60387690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.19092904 |
| 2 | MP0005360_urolithiasis | 5.77153990 |
| 3 | MP0005365_abnormal_bile_salt | 4.76898125 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.70558636 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.88456097 |
| 6 | MP0003252_abnormal_bile_duct | 3.26257358 |
| 7 | MP0010329_abnormal_lipoprotein_level | 2.93061572 |
| 8 | MP0009333_abnormal_splenocyte_physiolog | 2.93028212 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.67352125 |
| 10 | MP0009840_abnormal_foam_cell | 2.58032797 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.56294024 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.53403400 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.50899051 |
| 14 | MP0002398_abnormal_bone_marrow | 2.47883933 |
| 15 | MP0005083_abnormal_biliary_tract | 2.46784062 |
| 16 | MP0003866_abnormal_defecation | 2.26104842 |
| 17 | MP0000703_abnormal_thymus_morphology | 2.20445301 |
| 18 | MP0002405_respiratory_system_inflammati | 2.20111134 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.18210899 |
| 20 | MP0000609_abnormal_liver_physiology | 2.07849068 |
| 21 | MP0005332_abnormal_amino_acid | 2.05381820 |
| 22 | MP0002254_reproductive_system_inflammat | 2.03866890 |
| 23 | MP0002722_abnormal_immune_system | 1.95046260 |
| 24 | MP0005310_abnormal_salivary_gland | 1.83469596 |
| 25 | * MP0002429_abnormal_blood_cell | 1.80436143 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.76602202 |
| 27 | MP0003195_calcinosis | 1.75334011 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.73240886 |
| 29 | MP0004381_abnormal_hair_follicle | 1.68957074 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.67650192 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.67091979 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.67045918 |
| 33 | MP0003045_fibrosis | 1.62765603 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.59222363 |
| 35 | MP0003436_decreased_susceptibility_to | 1.57375462 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.52108418 |
| 37 | MP0003868_abnormal_feces_composition | 1.44815379 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.43988357 |
| 39 | MP0000685_abnormal_immune_system | 1.43191846 |
| 40 | MP0002163_abnormal_gland_morphology | 1.42628949 |
| 41 | MP0004130_abnormal_muscle_cell | 1.42276873 |
| 42 | MP0003724_increased_susceptibility_to | 1.40438448 |
| 43 | MP0009764_decreased_sensitivity_to | 1.39838996 |
| 44 | MP0008057_abnormal_DNA_replication | 1.37308429 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.35258865 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.31171521 |
| 47 | MP0008469_abnormal_protein_level | 1.27433066 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.27189346 |
| 49 | MP0001790_abnormal_immune_system | 1.27072335 |
| 50 | MP0005387_immune_system_phenotype | 1.27072335 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.26939831 |
| 52 | MP0005670_abnormal_white_adipose | 1.26642174 |
| 53 | MP0001800_abnormal_humoral_immune | 1.25958636 |
| 54 | MP0003303_peritoneal_inflammation | 1.23600016 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.22946790 |
| 56 | MP0009785_altered_susceptibility_to | 1.18187003 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.14019879 |
| 58 | MP0000598_abnormal_liver_morphology | 1.13888494 |
| 59 | MP0009763_increased_sensitivity_to | 1.13790870 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.13338867 |
| 61 | MP0004947_skin_inflammation | 1.12758453 |
| 62 | MP0002396_abnormal_hematopoietic_system | 1.11560153 |
| 63 | MP0000604_amyloidosis | 1.10604555 |
| 64 | MP0001764_abnormal_homeostasis | 1.10471642 |
| 65 | MP0002006_tumorigenesis | 1.09532575 |
| 66 | MP0005025_abnormal_response_to | 1.07462410 |
| 67 | MP0002933_joint_inflammation | 1.04453717 |
| 68 | MP0002419_abnormal_innate_immunity | 1.01640463 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.01474954 |
| 70 | MP0001873_stomach_inflammation | 0.99413521 |
| 71 | MP0005647_abnormal_sex_gland | 0.98919969 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.97968444 |
| 73 | MP0005451_abnormal_body_composition | 0.97945356 |
| 74 | MP0001845_abnormal_inflammatory_respons | 0.97748124 |
| 75 | MP0010368_abnormal_lymphatic_system | 0.97656247 |
| 76 | MP0002971_abnormal_brown_adipose | 0.97449483 |
| 77 | MP0001853_heart_inflammation | 0.95775697 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 0.95452829 |
| 79 | MP0002452_abnormal_antigen_presenting | 0.95284635 |
| 80 | MP0003448_altered_tumor_morphology | 0.95050257 |
| 81 | MP0010155_abnormal_intestine_physiology | 0.94240603 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.93936045 |
| 83 | MP0002723_abnormal_immune_serum | 0.93926938 |
| 84 | MP0005000_abnormal_immune_tolerance | 0.92406533 |
| 85 | MP0003186_abnormal_redox_activity | 0.92299630 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.88548726 |
| 87 | MP0006082_CNS_inflammation | 0.87602349 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 0.86256307 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.85769085 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.85063553 |
| 91 | MP0005334_abnormal_fat_pad | 0.83540273 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.82198627 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.80886380 |
| 94 | MP0005671_abnormal_response_to | 0.78924489 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.78691215 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.78360308 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 0.77915813 |
| 98 | MP0001663_abnormal_digestive_system | 0.77406737 |
| 99 | * MP0009642_abnormal_blood_homeostasis | 0.77386861 |
| 100 | MP0002060_abnormal_skin_morphology | 0.76046293 |
| 101 | MP0000858_altered_metastatic_potential | 0.75824870 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.75120242 |
| 103 | MP0002420_abnormal_adaptive_immunity | 0.74870918 |
| 104 | MP0001819_abnormal_immune_cell | 0.74815610 |
| 105 | MP0001881_abnormal_mammary_gland | 0.74734901 |
| 106 | MP0005275_abnormal_skin_tensile | 0.73503456 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.73281858 |
| 108 | MP0001756_abnormal_urination | 0.71339019 |
| 109 | MP0005023_abnormal_wound_healing | 0.68860220 |
| 110 | MP0000249_abnormal_blood_vessel | 0.68621458 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.68243900 |
| 112 | MP0000015_abnormal_ear_pigmentation | 0.67690396 |
| 113 | MP0009697_abnormal_copulation | 0.66957553 |
| 114 | MP0004510_myositis | 0.66826491 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.66724556 |
| 116 | MP0002009_preneoplasia | 0.65771642 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.65664581 |
| 118 | MP0005166_decreased_susceptibility_to | 0.65446161 |
| 119 | MP0002928_abnormal_bile_duct | 0.65198492 |
| 120 | MP0009115_abnormal_fat_cell | 0.64822355 |
| 121 | * MP0005636_abnormal_mineral_homeostasis | 0.64581626 |
| 122 | MP0003763_abnormal_thymus_physiology | 0.64253037 |
| 123 | MP0001919_abnormal_reproductive_system | 0.63399232 |
| 124 | MP0002796_impaired_skin_barrier | 0.62711324 |
| 125 | MP0001879_abnormal_lymphatic_vessel | 0.62499825 |
| 126 | * MP0000716_abnormal_immune_system | 0.62392067 |
| 127 | MP0002132_abnormal_respiratory_system | 0.62281876 |
| 128 | MP0001661_extended_life_span | 0.62161760 |
| 129 | MP0001851_eye_inflammation | 0.61766793 |
| 130 | MP0005645_abnormal_hypothalamus_physiol | 0.61671712 |
| 131 | MP0000689_abnormal_spleen_morphology | 0.61392602 |
| 132 | MP0003786_premature_aging | 0.61357839 |
| 133 | MP0001986_abnormal_taste_sensitivity | 0.60467805 |
| 134 | MP0010352_gastrointestinal_tract_polyps | 0.60154304 |
| 135 | MP0005220_abnormal_exocrine_pancreas | 0.60034961 |
| 136 | MP0002168_other_aberrant_phenotype | 0.59214359 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.58762112 |
| 138 | MP0008877_abnormal_DNA_methylation | 0.56949695 |
| 139 | MP0008872_abnormal_physiological_respon | 0.56649906 |
| 140 | MP0005174_abnormal_tail_pigmentation | 0.53776097 |
| 141 | MP0008260_abnormal_autophagy | 0.50794577 |
| 142 | MP0008873_increased_physiological_sensi | 0.50103144 |
| 143 | MP0004883_abnormal_blood_vessel | 0.49280056 |
| 144 | MP0000490_abnormal_crypts_of | 0.49245536 |
| 145 | * MP0002998_abnormal_bone_remodeling | 0.47285944 |
| 146 | MP0004808_abnormal_hematopoietic_stem | 0.46198641 |
| 147 | MP0002095_abnormal_skin_pigmentation | 0.45461916 |
| 148 | MP0000371_diluted_coat_color | 0.44789357 |
| 149 | MP0005377_hearing/vestibular/ear_phenot | 0.44317096 |
| 150 | MP0003878_abnormal_ear_physiology | 0.44317096 |
| 151 | MP0003787_abnormal_imprinting | 0.41659769 |
| 152 | MP0001501_abnormal_sleep_pattern | 0.39630529 |
| 153 | MP0004142_abnormal_muscle_tone | 0.38108703 |
| 154 | MP0003646_muscle_fatigue | 0.37654260 |
| 155 | MP0002102_abnormal_ear_morphology | 0.35564642 |
| 156 | MP0002083_premature_death | 0.33911027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.94774926 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.62251450 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.02000530 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 5.59325278 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.36524664 |
| 6 | Xanthomatosis (HP:0000991) | 5.28084680 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.27253725 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.19617198 |
| 9 | Abnormality of T cells (HP:0002843) | 5.19387776 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.12887530 |
| 11 | IgG deficiency (HP:0004315) | 4.98809237 |
| 12 | Complement deficiency (HP:0004431) | 4.96897889 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.92909456 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 4.87687362 |
| 15 | Severe combined immunodeficiency (HP:0004430) | 4.63867475 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 4.59276437 |
| 17 | Optic neuritis (HP:0100653) | 4.59276437 |
| 18 | Stomatitis (HP:0010280) | 4.58313344 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 4.56152866 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 4.51228747 |
| 21 | Agammaglobulinemia (HP:0004432) | 4.50316180 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.49305824 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 4.49305824 |
| 24 | Recurrent fungal infections (HP:0002841) | 4.48905422 |
| 25 | Recurrent bronchitis (HP:0002837) | 4.43806800 |
| 26 | Myositis (HP:0100614) | 4.35032572 |
| 27 | Encephalitis (HP:0002383) | 4.26982717 |
| 28 | Joint hemorrhage (HP:0005261) | 4.26608327 |
| 29 | Meningitis (HP:0001287) | 4.25611971 |
| 30 | Autoimmune hemolytic anemia (HP:0001890) | 4.20611308 |
| 31 | Myocardial infarction (HP:0001658) | 4.08021341 |
| 32 | Epidermoid cyst (HP:0200040) | 4.07272038 |
| 33 | Orchitis (HP:0100796) | 4.07175889 |
| 34 | Vasculitis (HP:0002633) | 4.06126377 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.98700088 |
| 36 | Increased IgM level (HP:0003496) | 3.95423590 |
| 37 | Hypolipoproteinemia (HP:0010981) | 3.90572127 |
| 38 | Abnormality of eosinophils (HP:0001879) | 3.88380545 |
| 39 | Chronic diarrhea (HP:0002028) | 3.82118619 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.78079175 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.76158917 |
| 42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.71269402 |
| 43 | Combined immunodeficiency (HP:0005387) | 3.68326276 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 3.66067883 |
| 45 | Abnormality of complement system (HP:0005339) | 3.63187278 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 3.62228492 |
| 47 | Hyperammonemia (HP:0001987) | 3.60002110 |
| 48 | Thyroiditis (HP:0100646) | 3.53735518 |
| 49 | Eosinophilia (HP:0001880) | 3.53663949 |
| 50 | Lymphopenia (HP:0001888) | 3.53620851 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 3.52422745 |
| 52 | Leukocytosis (HP:0001974) | 3.42624589 |
| 53 | Ketosis (HP:0001946) | 3.39558312 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 3.37860772 |
| 55 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.37429079 |
| 56 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.33879558 |
| 57 | Fat malabsorption (HP:0002630) | 3.33448192 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 3.29601526 |
| 59 | Recurrent skin infections (HP:0001581) | 3.27664445 |
| 60 | Recurrent abscess formation (HP:0002722) | 3.24859272 |
| 61 | Granulocytopenia (HP:0001913) | 3.22316607 |
| 62 | Hyperglycinuria (HP:0003108) | 3.21082266 |
| 63 | Keratoconjunctivitis (HP:0001096) | 3.19401818 |
| 64 | Abnormality of the intrinsic pathway (HP:0010989) | 3.18895949 |
| 65 | Abnormality of B cell number (HP:0010975) | 3.18248468 |
| 66 | Hypercholesterolemia (HP:0003124) | 3.15818037 |
| 67 | Hypoglycemic coma (HP:0001325) | 3.10080872 |
| 68 | Hypoplasia of the thymus (HP:0000778) | 3.08702893 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.07459112 |
| 70 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.05462134 |
| 71 | Pustule (HP:0200039) | 3.04010355 |
| 72 | Hemoptysis (HP:0002105) | 3.03711921 |
| 73 | IgM deficiency (HP:0002850) | 3.02032236 |
| 74 | Hyperglycinemia (HP:0002154) | 3.01899272 |
| 75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.99651468 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 2.99651468 |
| 77 | Abnormality of methionine metabolism (HP:0010901) | 2.98375299 |
| 78 | Hypoproteinemia (HP:0003075) | 2.95189577 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.94893787 |
| 80 | Mitral stenosis (HP:0001718) | 2.92054108 |
| 81 | B lymphocytopenia (HP:0010976) | 2.90277996 |
| 82 | IgA deficiency (HP:0002720) | 2.88182778 |
| 83 | Esophageal varix (HP:0002040) | 2.85417366 |
| 84 | Gingival bleeding (HP:0000225) | 2.85205630 |
| 85 | Conjugated hyperbilirubinemia (HP:0002908) | 2.83536754 |
| 86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.77007629 |
| 87 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.76491508 |
| 88 | Lymphoma (HP:0002665) | 2.75148026 |
| 89 | Abnormality of macrophages (HP:0004311) | 2.72659901 |
| 90 | Bronchitis (HP:0012387) | 2.67632787 |
| 91 | Spontaneous abortion (HP:0005268) | 2.66633016 |
| 92 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.65349797 |
| 93 | Gangrene (HP:0100758) | 2.63855723 |
| 94 | Obstructive lung disease (HP:0006536) | 2.61557179 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.61557179 |
| 96 | Skin nodule (HP:0200036) | 2.61387508 |
| 97 | Abnormality of the prostate (HP:0008775) | 2.61207416 |
| 98 | Chest pain (HP:0100749) | 2.60299617 |
| 99 | Hepatocellular carcinoma (HP:0001402) | 2.59059635 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 2.58877965 |
| 101 | Abnormality of the pleura (HP:0002103) | 2.58586756 |
| 102 | Gastrointestinal stroma tumor (HP:0100723) | 2.57808736 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.57121576 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 2.55642048 |
| 105 | Recurrent sinusitis (HP:0011108) | 2.52894015 |
| 106 | Chronic otitis media (HP:0000389) | 2.46914844 |
| 107 | Acanthocytosis (HP:0001927) | 2.46344220 |
| 108 | Steatorrhea (HP:0002570) | 2.46268493 |
| 109 | Ketoacidosis (HP:0001993) | 2.41601183 |
| 110 | Hyperbilirubinemia (HP:0002904) | 2.37788703 |
| 111 | Glomerulonephritis (HP:0000099) | 2.35178442 |
| 112 | Hypergammaglobulinemia (HP:0010702) | 2.34917985 |
| 113 | Menorrhagia (HP:0000132) | 2.34054415 |
| 114 | Arterial thrombosis (HP:0004420) | 2.34015479 |
| 115 | Anorexia (HP:0002039) | 2.32886795 |
| 116 | Spastic diplegia (HP:0001264) | 2.31274871 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.30664695 |
| 118 | Increased IgE level (HP:0003212) | 2.30479246 |
| 119 | Thrombophlebitis (HP:0004418) | 2.27087703 |
| 120 | Verrucae (HP:0200043) | 2.26905264 |
| 121 | Papilloma (HP:0012740) | 2.26905264 |
| 122 | Vascular calcification (HP:0004934) | 2.26851521 |
| 123 | Polycythemia (HP:0001901) | 2.26307293 |
| 124 | Increased mean platelet volume (HP:0011877) | 2.25950135 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 2.24078643 |
| 126 | Hydroxyprolinuria (HP:0003080) | 2.24078643 |
| 127 | Stomach cancer (HP:0012126) | 2.23358557 |
| 128 | Amyloidosis (HP:0011034) | 2.20264344 |
| 129 | Abnormal platelet volume (HP:0011876) | 2.19988850 |
| 130 | Colitis (HP:0002583) | 2.18245614 |
| 131 | Cardiovascular calcification (HP:0011915) | 2.16145416 |
| 132 | Nephritis (HP:0000123) | 2.14600596 |
| 133 | Spontaneous hematomas (HP:0007420) | 2.14136046 |
| 134 | Aplastic anemia (HP:0001915) | 2.14057045 |
| 135 | Chronic sinusitis (HP:0011109) | 2.13875581 |
| 136 | Pulmonary embolism (HP:0002204) | 2.12061228 |
| 137 | Metabolic acidosis (HP:0001942) | 2.05490360 |
| 138 | Abnormality of iron homeostasis (HP:0011031) | 2.05467091 |
| 139 | Keratitis (HP:0000491) | 2.04283649 |
| 140 | Pancreatitis (HP:0001733) | 2.02974508 |
| 141 | Abnormality of serum amino acid levels (HP:0003112) | 2.02885871 |
| 142 | Hypertriglyceridemia (HP:0002155) | 2.02478329 |
| 143 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02470429 |
| 144 | Skin rash (HP:0000988) | 2.00697822 |
| 145 | Hematochezia (HP:0002573) | 1.99833742 |
| 146 | Hypochromic microcytic anemia (HP:0004840) | 1.99626231 |
| 147 | Basal cell carcinoma (HP:0002671) | 1.99141152 |
| 148 | Glomerulopathy (HP:0100820) | 1.98120566 |
| 149 | Eczematoid dermatitis (HP:0000976) | 1.96042830 |
| 150 | Epistaxis (HP:0000421) | 1.95180608 |
| 151 | Abnormal cartilage morphology (HP:0002763) | 1.92630402 |
| 152 | Hypochromic anemia (HP:0001931) | 1.92329269 |
| 153 | Autoimmune thrombocytopenia (HP:0001973) | 1.92105568 |
| 154 | Gingivitis (HP:0000230) | 1.90937905 |
| 155 | Sepsis (HP:0100806) | 1.90805518 |
| 156 | Recurrent viral infections (HP:0004429) | 1.89407563 |
| 157 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.86204475 |
| 158 | Polyneuropathy (HP:0001271) | 1.86065984 |
| 159 | Neutropenia (HP:0001875) | 1.85203479 |
| 160 | Alveolar cell carcinoma (HP:0006519) | 1.84987850 |
| 161 | Sensorimotor neuropathy (HP:0007141) | 1.84817683 |
| 162 | Urticaria (HP:0001025) | 1.84236350 |
| 163 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84192300 |
| 164 | Dicarboxylic aciduria (HP:0003215) | 1.84192300 |
| 165 | Gastrointestinal infarctions (HP:0005244) | 1.83926981 |
| 166 | Stroke (HP:0001297) | 1.83461732 |
| 167 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.80774806 |
| 168 | Recurrent otitis media (HP:0000403) | 1.80685684 |
| 169 | Malnutrition (HP:0004395) | 1.80083684 |
| 170 | Delayed CNS myelination (HP:0002188) | 1.79870808 |
| 171 | Gout (HP:0001997) | 1.79646781 |
| 172 | Abnormal gallbladder morphology (HP:0012437) | 1.79276776 |
| 173 | Cholelithiasis (HP:0001081) | 1.78854041 |
| 174 | Hypoglycemic seizures (HP:0002173) | 1.78699992 |
| 175 | Hemiplegia (HP:0002301) | 1.78560093 |
| 176 | Joint swelling (HP:0001386) | 1.78462408 |
| 177 | Arthralgia (HP:0002829) | 1.78106258 |
| 178 | Restrictive lung disease (HP:0002091) | 1.76554827 |
| 179 | Abnormality of the pericardium (HP:0001697) | 1.75377679 |
| 180 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.73871471 |
| 181 | Peritonitis (HP:0002586) | 1.73250396 |
| 182 | Elevated hepatic transaminases (HP:0002910) | 1.71920483 |
| 183 | Neonatal onset (HP:0003623) | 1.71606291 |
| 184 | Acute hepatic failure (HP:0006554) | 1.71187940 |
| 185 | Conjunctival telangiectasia (HP:0000524) | 1.67737790 |
| 186 | Abnormal platelet function (HP:0011869) | 1.66070277 |
| 187 | Impaired platelet aggregation (HP:0003540) | 1.66070277 |
| 188 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.65600260 |
| 189 | Inflammation of the large intestine (HP:0002037) | 1.64274330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 3.67238069 |
| 2 | ERN1 | 3.52717815 |
| 3 | SIK1 | 3.12382811 |
| 4 | TYK2 | 2.98279414 |
| 5 | BCKDK | 2.94042396 |
| 6 | RIPK4 | 2.72853357 |
| 7 | FES | 2.49897755 |
| 8 | TRIB3 | 2.36111015 |
| 9 | MAP3K14 | 2.34251447 |
| 10 | JAK1 | 2.32353470 |
| 11 | MAP4K1 | 2.26717059 |
| 12 | FRK | 2.14661828 |
| 13 | MAP3K10 | 2.12530523 |
| 14 | TAOK3 | 2.12511201 |
| 15 | PKN2 | 2.01574027 |
| 16 | FGFR3 | 1.97227356 |
| 17 | TBK1 | 1.96527659 |
| 18 | JAK3 | 1.89039523 |
| 19 | IKBKE | 1.79283989 |
| 20 | GRK6 | 1.73361555 |
| 21 | TGFBR2 | 1.68947615 |
| 22 | TTN | 1.63958332 |
| 23 | PTK6 | 1.59723850 |
| 24 | CAMK1D | 1.55864568 |
| 25 | FGFR2 | 1.52055521 |
| 26 | EPHB1 | 1.46408601 |
| 27 | CAMKK2 | 1.43496033 |
| 28 | NEK9 | 1.40635764 |
| 29 | JAK2 | 1.39830567 |
| 30 | RIPK1 | 1.37468706 |
| 31 | FLT3 | 1.36825365 |
| 32 | CSK | 1.36717504 |
| 33 | INSRR | 1.36271696 |
| 34 | MAP3K13 | 1.33527332 |
| 35 | MST4 | 1.32196787 |
| 36 | PASK | 1.31926253 |
| 37 | MST1R | 1.31797319 |
| 38 | CSF1R | 1.27170117 |
| 39 | MAP3K7 | 1.26913609 |
| 40 | MAPK11 | 1.24467540 |
| 41 | IRAK1 | 1.23890958 |
| 42 | PRPF4B | 1.23021764 |
| 43 | LATS1 | 1.22789157 |
| 44 | KIT | 1.22303094 |
| 45 | TNK2 | 1.21701183 |
| 46 | PRKAA2 | 1.21099685 |
| 47 | MAP2K3 | 1.20734394 |
| 48 | IRAK3 | 1.20712551 |
| 49 | PIK3CG | 1.19956576 |
| 50 | LRRK2 | 1.18524721 |
| 51 | IKBKB | 1.17866093 |
| 52 | ITK | 1.14228002 |
| 53 | ADRBK2 | 1.11654982 |
| 54 | EPHA3 | 1.09522629 |
| 55 | ZAP70 | 1.09448097 |
| 56 | STK10 | 1.08060883 |
| 57 | KDR | 0.98456190 |
| 58 | SIK3 | 0.97055078 |
| 59 | TIE1 | 0.96089399 |
| 60 | BMPR2 | 0.94978854 |
| 61 | ERBB4 | 0.92942629 |
| 62 | EEF2K | 0.90980803 |
| 63 | MAP2K6 | 0.90206083 |
| 64 | BLK | 0.89120100 |
| 65 | CHUK | 0.88149064 |
| 66 | TLK1 | 0.86143357 |
| 67 | CAMK1G | 0.85586806 |
| 68 | EIF2AK3 | 0.84800133 |
| 69 | GRK7 | 0.83189558 |
| 70 | TESK2 | 0.82686001 |
| 71 | MAP3K3 | 0.82648131 |
| 72 | BTK | 0.82575407 |
| 73 | CDK6 | 0.77775676 |
| 74 | CAMKK1 | 0.73497072 |
| 75 | TYRO3 | 0.73379627 |
| 76 | SYK | 0.72974800 |
| 77 | HIPK2 | 0.72160501 |
| 78 | HCK | 0.70841265 |
| 79 | PRKCQ | 0.70287690 |
| 80 | TXK | 0.70287555 |
| 81 | LCK | 0.66893957 |
| 82 | MAPK12 | 0.64914914 |
| 83 | SIK2 | 0.64713735 |
| 84 | TEC | 0.64546693 |
| 85 | IRAK4 | 0.62124711 |
| 86 | NLK | 0.61878557 |
| 87 | SGK3 | 0.61830894 |
| 88 | PDGFRA | 0.61429738 |
| 89 | PIM1 | 0.60807475 |
| 90 | CLK1 | 0.58781924 |
| 91 | PIK3CA | 0.58442404 |
| 92 | STK3 | 0.57233392 |
| 93 | MAPK4 | 0.54777001 |
| 94 | DYRK1B | 0.53652877 |
| 95 | NUAK1 | 0.52898834 |
| 96 | GSK3A | 0.51862091 |
| 97 | RET | 0.51733957 |
| 98 | TRPM7 | 0.51534214 |
| 99 | PRKAA1 | 0.51237795 |
| 100 | PDK1 | 0.50738262 |
| 101 | PKN1 | 0.50324683 |
| 102 | PDPK1 | 0.50247455 |
| 103 | FYN | 0.49773705 |
| 104 | MAP3K11 | 0.49758796 |
| 105 | EGFR | 0.49397103 |
| 106 | MAP3K1 | 0.47910501 |
| 107 | RPS6KA5 | 0.47683825 |
| 108 | FGR | 0.46598165 |
| 109 | BMX | 0.45124038 |
| 110 | PDGFRB | 0.44566346 |
| 111 | STK4 | 0.43547717 |
| 112 | MAPK7 | 0.43235521 |
| 113 | PRKCH | 0.41300599 |
| 114 | CDK9 | 0.41242608 |
| 115 | LYN | 0.40056594 |
| 116 | MARK3 | 0.38650728 |
| 117 | IGF1R | 0.38591665 |
| 118 | ABL1 | 0.38390741 |
| 119 | CDK4 | 0.38190968 |
| 120 | MAPKAPK2 | 0.37928767 |
| 121 | SGK2 | 0.37424768 |
| 122 | MTOR | 0.37244068 |
| 123 | MATK | 0.37235222 |
| 124 | MELK | 0.34979853 |
| 125 | RPS6KA4 | 0.34968998 |
| 126 | PRKD1 | 0.32791865 |
| 127 | MAP3K2 | 0.30877130 |
| 128 | ACVR1B | 0.30876825 |
| 129 | ZAK | 0.29990433 |
| 130 | OBSCN | 0.29558912 |
| 131 | MAPKAPK3 | 0.29481844 |
| 132 | INSR | 0.29058314 |
| 133 | GRK1 | 0.25597726 |
| 134 | NEK6 | 0.23442860 |
| 135 | TAOK2 | 0.21767595 |
| 136 | ADRBK1 | 0.19977101 |
| 137 | MAPK3 | 0.17787683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.27821276 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.00175205 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.99157038 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.97482625 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.46697981 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25709162 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.09248809 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.96109278 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.90744191 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87207254 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.82497822 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80647280 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.69386702 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63544794 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.59622576 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55043545 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29678425 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29153439 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25581746 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.17510515 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.14587024 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.13358811 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11512194 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.97012377 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.93934346 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91381873 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.85936956 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.84302240 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77589089 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70937691 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67782804 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61712338 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59312729 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57827075 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56784156 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53063921 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49485274 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48626785 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.47066017 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45242934 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43710026 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39179574 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.39058784 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.38725224 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37162682 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30945741 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30535659 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27614475 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26345707 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17431326 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14824639 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14143283 |
| 53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.13980045 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 1.13081490 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10379381 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08181669 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04437110 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99890146 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.97621653 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.96885555 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94043048 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92950198 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 0.92750008 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.90569223 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90222543 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86181687 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85628145 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81227146 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81182404 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80947485 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80776810 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80253625 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79596153 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78485884 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78472810 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76137698 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.75233840 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.70599829 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68521008 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68207719 |
| 81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65975081 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65791591 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65184395 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.60729081 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59836534 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58980101 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58007415 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57320101 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57111691 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55714713 |
| 91 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54714787 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.52766894 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50540091 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.50422723 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50317753 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49972082 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49260759 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45715224 |
| 99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45548426 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45505355 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44520421 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44429530 |
| 103 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43997167 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43190535 |
| 105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41917319 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41727735 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39853743 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39803423 |
| 109 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39111548 |
| 110 | Phototransduction_Homo sapiens_hsa04744 | 0.38043599 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36951547 |
| 112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36367520 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.36059173 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35825811 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.35030076 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | 0.34964652 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34084220 |
| 118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33273849 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31505318 |
| 120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31075085 |
| 121 | Homologous recombination_Homo sapiens_hsa03440 | 0.30828382 |
| 122 | RNA polymerase_Homo sapiens_hsa03020 | 0.29793267 |
| 123 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.29761722 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29585738 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27826820 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.27206388 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26225343 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25301417 |
| 129 | Malaria_Homo sapiens_hsa05144 | 0.25249189 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.24296735 |
| 131 | Pertussis_Homo sapiens_hsa05133 | 0.23366092 |
| 132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23190914 |
| 133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22546166 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22341669 |
| 135 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.21787787 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.21766828 |
| 137 | Ribosome_Homo sapiens_hsa03010 | 0.21095848 |
| 138 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.21076674 |
| 139 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20528856 |
| 140 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20044590 |
| 141 | Influenza A_Homo sapiens_hsa05164 | 0.19595610 |
| 142 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.18331788 |
| 143 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.18304781 |
| 144 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17445656 |
| 145 | Protein export_Homo sapiens_hsa03060 | 0.17213189 |
| 146 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.16471575 |
| 147 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15626336 |
| 148 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.15188524 |
| 149 | Amoebiasis_Homo sapiens_hsa05146 | 0.14812633 |
| 150 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14604115 |
| 151 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.14445241 |
| 152 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14349295 |
| 153 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.14184368 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14182622 |
| 155 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.12905893 |
| 156 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12730923 |
| 157 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.12455009 |
| 158 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12197973 |
| 159 | Spliceosome_Homo sapiens_hsa03040 | 0.12112877 |
| 160 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11551005 |
| 161 | Endocytosis_Homo sapiens_hsa04144 | 0.09907561 |
| 162 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.09355722 |
| 163 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.08577601 |
| 164 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07979998 |
| 165 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.07369204 |
| 166 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07310231 |
| 167 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06894041 |
| 168 | Basal transcription factors_Homo sapiens_hsa03022 | 0.05901817 |
| 169 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05486317 |
| 170 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.05409370 |
| 171 | Colorectal cancer_Homo sapiens_hsa05210 | 0.03910198 |
| 172 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.03639762 |

